BioCentury
ARTICLE | Company News

GZMO, BruCells in licensing deal

June 4, 2001 7:00 AM UTC

BruCells (Brussels, Belgium) granted Genzyme Molecular Oncology (GZMO) an exclusive license to its technology for the fusion of dendritic and tumor cells. GZMO also will sponsor a two-year research pr...